Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant Intensity Modulated Whole-Abdominal Radiation Therapy for High-Risk Patients With Ovarian Cancer (International Federation of Gynecology and Obstetrics Stage III): First Results of a Prospective Phase 2 Study.
Arians N, Kieser M, Benner L, Rochet N, Katayama S, Sterzing F, Herfarth K, Schubert K, Schröder L, Leitzen C, Schneeweiss A, Sohn C, Debus J, Lindel K. Arians N, et al. Among authors: lindel k. Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):912-920. doi: 10.1016/j.ijrobp.2017.06.2465. Epub 2017 Jul 4. Int J Radiat Oncol Biol Phys. 2017. PMID: 28870790 Clinical Trial.
Second breast conserving therapy after ipsilateral breast tumor recurrence - a 10-year experience of re-irradiation.
Forster T, Akbaba S, Schmitt D, Krug D, El Shafie R, Oelmann-Avendano J, Lindel K, König L, Arians N, Bernhardt D, Marmé F, Schneeweiss A, Heil J, Sohn C, Debus J, Hörner-Rieber J. Forster T, et al. Among authors: lindel k. J Contemp Brachytherapy. 2019 Aug;11(4):312-319. doi: 10.5114/jcb.2019.87001. Epub 2019 Aug 29. J Contemp Brachytherapy. 2019. PMID: 31523231 Free PMC article.
Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study.
Arians N, Kieser M, Benner L, Rochet N, Schröder L, Katayama S, Herfarth K, Schubert K, Schneeweiss A, Sohn C, Lindel K, Debus J. Arians N, et al. Among authors: lindel k. Radiat Oncol. 2019 Oct 21;14(1):179. doi: 10.1186/s13014-019-1381-2. Radiat Oncol. 2019. PMID: 31639066 Free PMC article. Clinical Trial.
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Meixner E, Wark A, Forster T, Weykamp F, Lang K, König L, Lindel K, Oelmann-Avendano JT, Krisam J, Schneeweiss A, Ellerbrock M, Mielke T, Hörner-Rieber J, Herfarth K, Debus J, Arians N. Meixner E, et al. Among authors: lindel k. Radiat Oncol. 2023 Jan 9;18(1):5. doi: 10.1186/s13014-023-02198-4. Radiat Oncol. 2023. PMID: 36624483 Free PMC article. Clinical Trial.
Treatment Tolerability and Toxicity of Postoperative Proton Beam Therapy for Gynecologic Malignancies: Results of the Prospective Phase 2 APROVE Trial.
Arians N, Lindel K, Krisam J, Oelmann-Avendano JT, Meixner E, König L, Hoerner-Rieber J, Wark A, Forster T, Weykamp F, Lang K, Schneeweiss A, Ellerbrock M, Mielke T, Herfarth K, Debus J. Arians N, et al. Among authors: lindel k. Int J Radiat Oncol Biol Phys. 2023 Jul 15;116(4):825-836. doi: 10.1016/j.ijrobp.2023.01.004. Epub 2023 Jan 13. Int J Radiat Oncol Biol Phys. 2023. PMID: 36642110 Free article. Clinical Trial.
66 results